-
1
-
-
77951875017
-
Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies
-
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration
-
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010; 375:1634-1639.
-
(2010)
Lancet
, vol.375
, pp. 1634-1639
-
-
Sarwar, N.1
Sandhu, M.S.2
Ricketts, S.L.3
-
2
-
-
33645978418
-
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease
-
Goldberg IJ, Ginsberg HN. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 2006; 130:1343-1346.
-
(2006)
Gastroenterology
, vol.130
, pp. 1343-1346
-
-
Goldberg, I.J.1
Ginsberg, H.N.2
-
3
-
-
33947108446
-
Nonalcoholic fatty liver disease and increased risk of cardiovascular disease
-
Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191:235-240.
-
(2007)
Atherosclerosis
, vol.191
, pp. 235-240
-
-
Targher, G.1
Arcaro, G.2
-
4
-
-
77950499307
-
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity
-
Chan DC, Nguyen MN, Watts GF, et al. Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity. Am J Clin Nutr 2010; 91:900-906.
-
(2010)
Am J Clin Nutr
, vol.91
, pp. 900-906
-
-
Chan, D.C.1
Nguyen, M.N.2
Watts, G.F.3
-
5
-
-
67349267865
-
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria
-
Bell S, Cooney J, Packard CJ, et al. Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria. Atherosclerosis 2009; 205:296-301.
-
(2009)
Atherosclerosis
, vol.205
, pp. 296-301
-
-
Bell, S.1
Cooney, J.2
Packard, C.J.3
-
6
-
-
70349902776
-
Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy
-
Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009; 94:3842-3848.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 3842-3848
-
-
Cussons, A.J.1
Watts, G.F.2
Mori, T.A.3
Stuckey, B.G.4
-
7
-
-
77649216380
-
Review article: Omega-3 fatty acids - A promising novel therapy for nonalcoholic fatty liver disease
-
Masterton GS, Plevris JN, Hayes PC. Review article: omega-3 fatty acids - a promising novel therapy for nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2010; 31:679-692.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 679-692
-
-
Masterton, G.S.1
Plevris, J.N.2
Hayes, P.C.3
-
8
-
-
0042206849
-
Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels
-
Stresa Workshop Participants
-
Katan MB, Grundy SM, Jones P, et al., Stresa Workshop Participants. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78:965-978.
-
(2003)
Mayo Clin Proc
, vol.78
, pp. 965-978
-
-
Katan, M.B.1
Grundy, S.M.2
Jones, P.3
-
9
-
-
42649086181
-
The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations
-
Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008; 27:117-126.
-
(2008)
J Am Coll Nutr
, vol.27
, pp. 117-126
-
-
Naumann, E.1
Plat, J.2
Kester, A.D.3
Mensink, R.P.4
-
10
-
-
66749118878
-
A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients
-
Plat J, Brufau G, Dallinga-Thie GM, et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009; 139:1143-1149.
-
(2009)
J Nutr
, vol.139
, pp. 1143-1149
-
-
Plat, J.1
Brufau, G.2
Dallinga-Thie, G.M.3
-
11
-
-
71149093699
-
Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production
-
Plat J, Mensink RP. Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production. Lipids 2009; 44:1149-1153.
-
(2009)
Lipids
, vol.44
, pp. 1149-1153
-
-
Plat, J.1
Mensink, R.P.2
-
12
-
-
77952674608
-
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet
-
Chan DC, Watts GF, Gan SK, et al. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010; 33:1134-1139.
-
(2010)
Diabetes Care
, vol.33
, pp. 1134-1139
-
-
Chan, D.C.1
Watts, G.F.2
Gan, S.K.3
-
13
-
-
33845511343
-
Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols
-
Demonty I, Chan YM, Pelled D, Jones PJ. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 2006; 84:1534-1542.
-
(2006)
Am J Clin Nutr
, vol.84
, pp. 1534-1542
-
-
Demonty, I.1
Chan, Y.M.2
Pelled, D.3
Jones, P.J.4
-
14
-
-
77951632835
-
Prevention and treatment of nonalcoholic fatty liver disease
-
Targher G, Bellis A, Fornengo P, et al. Prevention and treatment of nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42:331-340.
-
(2010)
Dig Liver Dis
, vol.42
, pp. 331-340
-
-
Targher, G.1
Bellis, A.2
Fornengo, P.3
-
15
-
-
77951874018
-
NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal AJ, Chalasani N, Kowdley KV, et al., NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362:1675-1685.
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
16
-
-
77950202777
-
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
-
Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 362:1142-1143.
-
(2010)
N Engl J Med
, vol.362
, pp. 1142-1143
-
-
Petersen, K.F.1
Dufour, S.2
Hariri, A.3
-
17
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40:1461-1465.
-
(2008)
Nat Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
|